BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36722453)

  • 1. Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis.
    Ding B; Lou W; Fan W; Pan J
    Environ Toxicol; 2023 May; 38(5):1038-1052. PubMed ID: 36722453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
    Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
    Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhou SJ; Liu FY; Zhang AH; Liang HF; Wang Y; Ma R; Jiang YH; Sun NF
    Br J Cancer; 2017 Jul; 117(2):233-244. PubMed ID: 28588321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
    Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
    Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.
    Wang Y; Sun B; Zhao X; Zhao N; Sun R; Zhu D; Zhang Y; Li Y; Gu Q; Dong X; Wang M; An J
    Oncotarget; 2016 Apr; 7(17):24383-401. PubMed ID: 27027434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.
    Guo D; Li Y; Chen Y; Zhang D; Wang X; Lu G; Ren M; Lu X; He S
    Cell Prolif; 2019 Jul; 52(4):e12628. PubMed ID: 31038266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3.
    Wang X; Wei P; Yang L; Liu F; Tong X; Yang X; Su L
    Chin Med J (Engl); 2022 Sep; 135(17):2089-2097. PubMed ID: 35143426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.
    Li C; Zhou D; Hong H; Yang S; Zhang L; Li S; Hu P; Ren H; Mei Z; Tang H
    Aging (Albany NY); 2019 Aug; 11(15):5593-5612. PubMed ID: 31402791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT.
    Li W; Jiang Y; Pan Q; Yang G
    Adv Clin Exp Med; 2023 May; 32(5):575-582. PubMed ID: 36530029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway.
    Tan A; Li Q; Chen L
    Arch Biochem Biophys; 2019 Jan; 661():196-202. PubMed ID: 30468709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p.
    Chen PP; Zhang ZS; Wu JC; Zheng JF; Lin F
    Cell Signal; 2021 Aug; 84():109992. PubMed ID: 33774129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAF-Released Exosomal miR-20a-5p Facilitates HCC Progression via the LIMA1-Mediated β-Catenin Pathway.
    Qi Y; Wang H; Zhang Q; Liu Z; Wang T; Wu Z; Wu W
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/β-catenin pathway.
    Liu P; Chen B; Gu Y; Liu Q
    Biomed Pharmacother; 2018 Dec; 108():492-499. PubMed ID: 30243081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
    Huang Y; Huang H; Li M; Zhang X; Liu Y; Wang Y
    Biomed Pharmacother; 2017 Oct; 94():1038-1047. PubMed ID: 28810526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yao B; Li Y; Wang L; Chen T; Niu Y; Liu Q; Liu Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3885-3895. PubMed ID: 31561723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.